Metformin is not recommended for people with severe kidney disease
Some individuals notice reduced appetite and weight loss within a few weeks, while for others, it may take several months
District Judge Karen Marston as part of a GLP-1 lawsuit multidistrict litigation (MDL)
Retatrutide combines agonism of GIP, GLP-1, and Glucagon receptors in a single molecule, a physiological strategy that researchers believe can unlock even greater metabolic potential
Focus on consuming nutrient-dense foods that are rich in essential vitamins and minerals
Key findings, including the potential protective effects of GLP-1RAs on schizophrenia, anxiety disorders, and autism, were consistently observed across multiple independent datasets, reinforcing the robustness and reproducibility of the results